Unicycive Therapeutics, Inc. (UNCY) SEC Filings — 2025
19 SEC filings for Unicycive Therapeutics, Inc. (UNCY) in 2025.
Filings
- Unicycive Therapeutics Files 8-K Report — 8-K · Nov 14, 2025
- Unicycive's Cash Boosted by Offering, Net Loss Widens Q3 — 10-Q · Nov 12, 2025
- Unicycive Therapeutics Files 8-K Report — 8-K · Oct 28, 2025
- Unicycive Therapeutics Files 8-K — 8-K · Aug 18, 2025
- Unicycive Therapeutics Files 8-K Report — 8-K · Aug 15, 2025
- Unicycive Swings to Loss Amid Soaring G&A, R&D Cuts — 10-Q · Aug 14, 2025
- Unicycive Therapeutics Files 8-K — 8-K · Jul 8, 2025
- Unicycive Therapeutics Files 8-K — 8-K · Jun 30, 2025
- Unicycive Therapeutics Files 8-K with Corporate Updates — 8-K · Jun 20, 2025
- Unicycive Therapeutics Files 8-K — 8-K · Jun 10, 2025
- Unicycive Therapeutics Files 8-K on Shareholder Votes & Financials — 8-K · Jun 9, 2025
- Unicycive Therapeutics Files Proxy Statement Supplement — DEFA14A · May 22, 2025
- Unicycive Therapeutics Files 8-K Report — 8-K · May 21, 2025
- Unicycive Therapeutics Files Q1 2025 10-Q — 10-Q · May 14, 2025
- Unicycive Therapeutics Files Proxy Statement Supplement — DEFA14A · May 7, 2025
- Unicycive Therapeutics Files Definitive Proxy Statement — DEF 14A · Apr 30, 2025
- Unicycive Therapeutics Files 8-K Amendment — 8-K/A · Apr 14, 2025
- Unicycive Therapeutics Files 2024 Annual Report — 10-K · Mar 31, 2025
- Unicycive Therapeutics Files 8-K Report — 8-K · Jan 7, 2025